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m7283 HighPreesureInflationinConjunctionwithTiclopidineandAepirinFoliowingCoronaryStent
Placement:ReeultsoftheSTRESSIliTriai
D.L. Fiechman, M.P. Savage, 1.Penn, J. Hirehfeld, M. Nobuyoshi, S. Ellis,
J. Moses, J. Werner, R. Rake, S. Gebhardt, C. Dempsey, D. Rehmann, for
the Sheldon Goldberg for the STRESS Ill Investigators. Jefferson Medical
College, Philadelphia, PA, USA
STRESS Ill is a prospective, multicenter trial to assesa acute and long-term
outcomes of single Palmaz-Sehatz stent placement for new focal lesions
in native corona~ arteries using high pressure inflation in conjunction with
ticlopidine and aspirin. The inclusion criteria are identical to thoee of the
original STRESStrial. Enrollment of 250patienteat 15centerswascompletd
in August 1996 with 6 month angicgraphy to be completed in February 1997.
Baseline patient demographics are closely matched, except for an increased
percentage of women (17% vs 26%, p = 0.06) and higher incidence of
hyperlipidemia (44% vs 61%, p = 0.02) in STRESS Ill patients. Procedural
success wee similar (96.1% VS96.77., p = ns). Compared with STRESS
stent patients, STRESS Ill patients had fewer stent thromboaea (3.4% vs
1.2Y0,p = 0.12) and bleeding and vaSCLdarcomplications (7.3% vs 0.6%,
p = 0.003). Length of hospital stay was redueed from 5.8 days to 1.6 days
(p < 0.0001). Quantitative coronary analysis has been completed on 193
pstienta. Interim resulta revealed smaller baseline referance vessel aize
(3.04 vs 2.63 mm, p < 0.0001), greeter acute gain (1.72 vs 1.66 mm, p
= 0.02), and less residual stenosis (19% vs 9%, p c 0.0001) in STRESS
Ill compared with STRESS. Thus, the use of ticlopidine in conjunction with
high preeeure inflation resulted in improved early clinical and angiographic
outcomes compared with STRESS stent patients. Angiogrephic restenoais
and target lesion revaecularization will be compared to ascertain whether
these superior initial reeults will be translated into long-term benefit.
9:15
m7284 IntravaacuierUltrasoundResuitsfromthe ReducedAnticoagulstionVeinGraftStudy(RAVES)
A. Abizaid, G.S. Mintz, A.D. Pichard, L.F. Satler, K.M. Kent, S.G. Ellia,
M.P.Savage, J. Moses, S.R. Ramee, S.B. King, Ill, J. Griffin, M.B. Leon.
Washington Hospital Center, Washington, DC, USA
RAVES was a multicenter registry designed to test the safety of sole an-
tiplatelet (ASA and ticlopidine) therapy after Palmez-Schatz coronaty stent
implantation followed by high-pressure”adjuncf PTCAin 200 pts withvein graft
lesions. Intravascular ultrasound (IVUS) was performed at the completion of
the procedure not to guide, but to “document” final results. The adequacy of
stent implantation was judged by 3 IVUS parameters: full stent expansion
(minimum stent area ?60% reference lumen area), complete atent-vein graft
apposition, and stent symmetry (minimutimaximum stent diameter >0.7)}.
Resuits were compared to biinded quantitative coronary angiogrephy {QCA:
measurement of reference and minimum lumen diameters (MLD), in mm,
and diameter stenosis}.
Ivus QCA A r P
Reference 3.67* 0.66 3.03 +0.59 0.69 +0.49 0,681 <0.0001
MLD 3.09+0.55 2.S5 + 0.51 0.30+0.50 0.567 <0.0001
Stenosis 15* 11”/& 4 * 14% 10* 15 0.369 <0.0001
In 36%, stent implantation failed to meat 1 of the 3 criteria, most often
a stent area <60Y0 referance lumen area. Importantly, achieving optimal
IVUS etent implantation criteria was not associated with reduced subacute
stent thrombosis (O% overall!) or improved QCA final MLD. Other IVUS
findings inciuded infrequent (9%) stent-edge dissections and a surprisingly
large average plaque burden (41 + 10%) outside tha stented segment.
kVaconclude: Documentary IVUS after high-pressure stenting in vein graft
lesions (1) shows consistently greater lumen dimensions mmpsred with QCA
and (2) suggests that achieving “optimal” IVUS parameters may have little
effect on subacute thrombosis and final lumen diameters.
9:30
]~[ six Monthciinica,andAn~io~raPhic~u~comeAfier
IVUSGuidedStentimplantation
H. Mudre, M. Sunamura, H. Figulla, Y.Almagor, L. Bilodeau, 1.Penn,
A. Colombo, C. Harem, A. Bartorelli, M. Rothman, M. Nobuyoshi,
T. Yamaguchi, V. Voudris, S. Makovski, C. Hausmann, P.de Jaegere. Music
Study hrvestigatora, Rotterdam, The Netherlands
Preliminary date indiostethat systemic anticoagulation csn aafely be omitted
in case of IVUS guided stent implantation. The impact of IVUS guidance on
the long-term clinical and angiographic outcome is less studiad. Therefora,
major cardiac events as well aa changes in stenosis geometry (CAAS Sya-
tem) and restenosis rate (250% diameter stenosis) were aasessed in 161
ptewho received a single Palmaz-Schatz stent because of stable angina and
a de novo corona~ lesion. Pts meeting the IVUS critetla of optimal stant ex-
pansion only received ASA 2100 mg, while those not also received systemic
anticoegulation, Resu/ts:
Event In-hospital Discharge-6 month
Total Ranking Total Ranking
Death o 0 1 (0.60A) 1
Q-AMI 1 (0.60A) 1 1 (0.6%) 1
non-QAMI 6 (3.6%.) 6 0 0
CASG 1 (0.6”/0) o 2 (1.2%) 2
rePTCA 2 (1.2”/0) o *9 (6%)-(4°/0) 7
SAT 2 (1.2%) o 1 (0.6%) o
(“ including2ptewith repeat PTCA or another lesion)
QCA data are available in 131 pts: The MLD pre/post and at FU wea:
1.13, 2.91 and 2.17 mm, respectively. The incidence of restenosis was only
7%.
Cone/usions:ASA suffices in ceae of optimal stent expansion. in compar-
ison with historical series IVUS guidance substantially further reduces the
restenosis rate and need for subsequent PTCA.
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m CoronafYStentThromboai.:~anagementand
Long-termFollow-upResuit
H. Yokoi, H. Nosaka, T. Kimura, T. Tamura, Y. Nakegawa, N. Hameaaki,
M. Nobuyoshi. Kokura Memoria/ Hospita/, Kitakyushu, Japan
Despite the well-recognized incidence of stentthromboais, management and
late outcome of stent thrombosis have not been thoroughly defined. To eval-
uate the responsiveness to the proposed therapy and long-term follow-up
result, we reviewad 2649 coronaty stentings performed between June 1990
and June 1996. During the study period, stent thrombosis occurred in 46
patients (pts) (46 lesions) (1.7%) including 31 lesions (Ies) received Palmez-
Schatz (1.7%), 6 Ies Gianturco-Roubin (2.0%), 5 Ies Strecker (9.3%), 3 Ies
Cordis (2.0%),2 Ies ACS (2.5%) and 1 Ies AVE stent (1.4%). Repeat balloon
angioplasty (BA) was performed in 45 Ies (94%), 10 of whom were treated by
additional stent implantations because of poor responsiveness to BA. Eigh-
teen pts (40%) received thrombolysis and 15 pts (33%) treated by intre-aortic
balloon pumping. Although successful recanalization of the artery, defined as
<50% residual stenosis with TIMI 3 flow, was achieved in all Ies, refractoy
stent thrombosis occurred in 5 Ies (11%). Seven pts (15%) died and 7 pts
(15%) required bypase surgery during same hospitalization. Stent thromix-
sis resulted in Q-wave Ml occurred in 14 pts (30%) and composite major
mmplicetions occurred in 24 pts (54Yo). FU quantitative angiography was
obtained from 25 pts after 6 months or earlier when indicated by symptoms.
Bina~ restenosis, defined as >50% DS at FU, occurred in 5 pta (19%).
Target lesion revascularization (TLR) was performed in 3 pts (12%). Clinical
FU data was obtained after 12 months. The rates of survival free of Ml and
bypass surgery were 64% at 1 year. Conclusion: 1)Despite the emergent
mechanical recenalization, stent thrombosis wee associated with significant
adverse clinical outcomas. 2) Long-term outcome waa similar to the historical
group of non-atent thrombosis pts.
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El7291 StentReconstructionof Occluded/Obstructediiiofemo’mlVeinsandinferiorVenaCavato
Re-estebiiehAccessfor FutureCardiac
CatheterizationandCardiacSurgery
F.F.Ing, T.E. Fagan, R.G. Grifka, M.R. Nihill, K.M. Shaffar, C.E. Mullins.
TexasChildren’s Hospital, Bay/or Co/lega of Medicine, Houston, TX, USA
Patientawith congenital heart disease who undergo repeated cardiac catheter-
izations and/or have had indwelling ‘femoral venous lines following cardiac
surgety may develop occiusione/obstructions of their iliofemoral veins (IFV)
and inferior vena cava (IVC). Patients in whom further surgay or catheter-
izations are anticipated, inability to access the heart from the IFV may be
problematic. Methods: 10 pts, madian age 6.5 yra (range 0.5-11.4 yre), un-
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derwent implantation of 33 stenta in 8 IFV (5 occluded, 3 obstructed) and
4 WC (2 occluded, 2 obstructed). While wires were passed across the cb
structed vessels for atent placement, occluded vessels required puncture
through the thrombosad sites using a stiff wire or transseptal needle. A
catheter placed from the internal jugular vein to the site of obstruction was
used as a guide for the puncture. Once crossed, the obstructed site was
serially dilated prior to stent implantation. Results: The mean diameter of 5
obstructed vessels was 2.3 + 3.2 mm. Following stent placement of all 12
vessels (occluded and obstructed), the mean diameter was 8.9 + 3.0 mm
(p < 0.05). 8/10 pts had long segments of occlusiorVobstruction requiring
2-7 overlapping stents. Further diagnostic catheterizations were petiormad
in 5 patients via the stented vessels at mean follow-up of 9.8 mo. All ves-
selslstents remained patent with mean diameter of6.4 + 2.0 mm. Inaddition,
the stentad vessel was utilized for endomyocardial biopsies in one pt and for
vascular access during subsequent cardiac surgery in another. Conclusion:
Oooludedlobstructed IFV and IVC maybe reconstructed using stents to re-
established venous access to the heart for future cardiac catheterizations
ardor surgeries.
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729-2 TranshapsticThsrspauticCardiacCathatsrizstion:A
NovalApproachfor tha Intarvantionalist
D. Shim, T.R. Lloyd’, R.H. Beekman, Ill. Chi/dren’s Hospital Medical
Centec Cincinnati, Ohio, USA, 1C.S. Motf Children’s Hospital, Ann Arboc
Michigan, USA
To evaluate efficacy and safety of transhepatic (TH) venous access for
interventional cardiac catheterization (CC), a retrospective review of 11 pts
with a median age of 19 mos (range: 1 dy-41 yra) and weight of 9.2 kg (3.1–
73.6 kg) was performed. Indications for TH access were bilateral obstructed
femoral veins (n=7), interrupted inferiorvenacava(n = 1),obstrucfedfemoral
veina and superior vena cava (n = 2), and presumptive improved route for
intervention via TH access (n = 3). Interventions performed via the TH route
included pulmonary valvuloplssfy (n = 3), pulmonary angioplasty (n = 2),
and 1 each of atrfal septal defect device closure, transseptal puncture with
mitral vahruloplasty,superfor vena csva stent placement, bilateral pulmonaty
angioplasty and stent placement, pulmonary stent redilation, and cardiac
biopsy. TH access was achieved in a median time of 9.0 min (3-12 rein) with
sheath sizes of 4-12 Fr.TH CC allowed successful interventions in 10/11pts
(91%). TH interventional CC was not successful in a newborn with critical
pulmonic stenosis and diminutive right ventricle; the advent of a precurved
TH sheath has subsequently facilitated catheter passsge across the tricuspid
valve. There were no changes in pre and lmst-TH CC hemoglobin levels
(mean + SD: 12.9+ 2.0 vs 12.1 + 2.2 gm/dL; p= NS) or alaninetrensferase
(36.9 + 27.9 vs 45.0 + 18.5 IU/L; p = NS). No complications of bleeding,
suboapsular Iiverhematoma, orpneumothorsx were notedon Iiverultrasound
or chest radiograph.
Conclusion: TH CC is safe and effective as a route for interventional
procedures for patients with limited venous access.
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n7293 TranacsthatarOccluaionof PatantDuctusArterioausandAorto-PulmonaryCollataralaUsing
tha Gianturco-GrifksVaacularOcclusionDavice
R.G. Grifka, F.F.Ing, W.S. McMahon, M.R. Nihill, M.P.O’Leughlin,
W.R. Morrow, J.W. Wiggins, C.E. Mullins. TexasChildren’s Hospital,
Houston, TX, USA
Devices have been developed for transcstheter vascular occlusion. The
present devices have limitations including inability to adjust device posi-
tion, embolization, and residual leaks. Two common congenital heart de-
fects which are occluded with devices are patent ductus arteriosus (PDA)
and aortopulmonary collateral vessels (Ao-PA). We report results using the
Gianturco-Grifka Vascular occlusion device (GGVOD) to occlude PDA and
Ao-PA. The GGVOD consists of a nylon sack attached to an end-hole
catheter; a filler wire is inserted through the catheter into sack.
In 17pts, 18vessels(15-PDA, 3-Ao-PA)were occluded usingthe GGVOD.
Age ranged from 2 mo to 61 yr (median 2.5 yr), weight ranged from 4.5
to 85 kg (median 9.4 kg). Vessel diameter ranged from 2.6 to 6.1 mm
(mean 4.1 mm). The QP:Qs = 2.1 + 0.44. The GGVOD was implanted in a
length of vessel ? the device diameter. The GGVOD size was 0.7–1.8 mm
larger than the vessel diameter. In 14 of 18 implants, prior to releasing the
GGVOD, the device was repositioned toanoptimal position. Inall 16vessels,
the GGVOD was implanted without problems, resulting in 100% complete
occlusion. There were no device embolizations.
All pta had follow-up clinic evaluations 1 to 16 mo post-GGVOD implant.
There have been no late device embolizations and eve~ vessel remains
completely occluded.
Conclusion: The GGVOD is a safe and effective transcstheter occlusion
device for tubular PDA and Ao-PA collateral vessels. The GGVOD maybe
useful to occlude additional vascular defects.
-l Ra.WningAfiar~uccassfu,~.il~c ,uaion~or
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PatentDuctuaArtariosua
C.J. Daniels, SC. Cassidy, D.W. Teske, J.J. Wheller, H.D. Allen. Columbus
Children’s Hospital and The Ohio State University, Columbus, Ohio, USA
Cardiac catheterization guided coil occlusion is an accepted method tocloae
patent ductus arteflosus (PDA). Procedural success is mnfirmed by an-
giography and post-catheterization Doppler-eohocardiography demonstrat-
ing obliteration of PDA flow into the pulmonary artery. During evaluation
of prospectively collected data on 23 patients who had PDA coil occlusion
using Gianturco spring coils from May 1995 to May 1996, we found some
that had reopened after carefully documented successful closure. This study
was performd to determine the number that reopened and any independent
variables that may be predictive of reopening. The study group included 16
patients who have completed a 6 month follow-up period. All had Doppler-
eohocardiogramswithin 24 hours and at4-6 months post-PDAcoil occlusion.
The patients that reopened after early successful closure were compared to
all other patients by stepwise regression analysis using independent vari-
ables including aga, sex, patient weight, catheterization date (early vs late
experience), hepsrin use, PDA minimal and maximal diameter, and PDA
length and by unpaired t-testing comparing PDA minimal diameter, maximal
diameter, and length. PDA early closure was successful in 16/18 patients
(69%). PDA reopening after successful closure was diagnosed at late follow-
up in 5 patients. Late coil migration was documented in 1 patient. Stepwise
regression analysis demonstrated that only PDA length significantly pre-
dicted PDA reopening (p < 0.01). Likewise, unpaired t-testing ahowed the
PDA length to be the only significant variable predictive of reopening. PDA
mean length was 2.9 (range 1.0 to 6.0) and 7.5 (range 3.7 to 12.0) mm, re-
spectively, for the reopened and all other patients (p < 0.01). For PDA length
<3.5 mm, positive and negative predictive values for reopening were 100%
and 93%, respectively. Short PDA length was the only independent vari-
able that significantly predicted reopening, suggesting that in such anatomy,
alternatives to coil occlusion should be considered.
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Comparisonof ths Rasuttsusingths Rashkind
UmbrellaandDiffarentTypssof OcclusionCoilsin
1,306procsdurssfroma EuropeanRsgistry
I.C. Huggon, S.A. Qureshi, for the European Registty. Guy’s Hospital,
London, UK
Patiicipating cardiologists submitted date to a registry recording attempted
transcatheter occlusion of the arterial duct. Details given included the de-
vices used, failures of implantation, embolisation of the device and time
course to echocardiographic complete occlusion. Results are available for
1,308 attempted procedures in 1,231 patienta. Of 992 Rashkind umbrella
procedures, 77 (7.77.) were fOr residual ducts fOllOWiflgligatiOnor preViOUS
transcstheter occlusion. Forty-four (14%) of 314 coil procedures were for
residual ducts. Jackson (Cook) or Duct Occlud controlled-release coils were
successfullydeployed in 275 procedures and other coil types oroombinations
in 29. The mean number of coils implanted per duct was 1.47. Controlled-
release coils embolised in 6 procedures (2.9%), standard roils in 4 (13.7%)
and Rashkind umbrellas in 23 (z.s~o). Kaplan-Meier curves for freadom from
residual flow after implantation of coils and umbrellas are shown. The pro-
portion with complete occlusion at 20 months was 64% with the umbrella
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